Clinical Trials Directory

Trials / Completed

CompletedNCT03572426

Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
164 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.

Detailed description

Adults ages 18-80 will be recruited if they are diagnosed with bipolar disorder, major depression, or have no mood symptoms. The adults will undergo a diagnostic interview, the Mini International Neuropsychiatric Interview (MINI) for the diagnosis. The subjects will also complete the Adverse Childhood Events Scale to evaluate for a genetic x environmental interaction in detecting bipolar disorder at initial assessment. Genotyping will be done by SNaPshot genotyping method and genetic sample will be collected via buccal swab.

Conditions

Interventions

TypeNameDescription
OTHERgenotyping all subjectsgenotyping using SNaPshot genotyping method.

Timeline

Start date
2018-06-13
Primary completion
2019-04-04
Completion
2019-04-04
First posted
2018-06-28
Last updated
2019-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03572426. Inclusion in this directory is not an endorsement.